Active disease There is very little data assessing response rates in active UC, as thiopurines have slow-onset of action. By mouth For Adult 0. With intravenous use. Agranulocytosis ; alopecia ; bone marrow disorders ; diarrhoea ; gastrointestinal disorders ; neoplasms ; photosensitivity reaction ; pneumonitis ; severe cutaneous adverse reactions SCARs. Low dose excretion occurs into breast milk for four hours following ingestion, therefore consider advising expressing and wasting milk during this time period. Uncommon Anaemia ; hepatic disorders ; hypersensitivity ; pancreatitis. Nausea Nausea is common early in the course of treatment and usually resolves after a few weeks without an alteration in dose.
Guidelines for prescribing azathioprine in dermatology based recommendations are made for routine safety monitoring of patients treated with azathioprine. Monitoring and Safety of Azathioprine Therapy in Inflammatory Dose recommendations for AZA vary slightly between Western guidelines.
Shared Care Guideline for Azathioprine, November Date of Patients on Azathioprine are under regular follow-up, which provides an.
Related Treatment Summaries Crohn's disease Cytotoxic drugs Eczema and psoriasis, drugs affecting the immune response Immune response Neuromuscular disorders Platelet disorders Rheumatic disease, suppressing drugs Rheumatoid arthritis Ulcerative colitis Other drugs classified as antimetabolites.
Neutropenia and thrombocytopenia Neutropenia is dose-dependent.
AZATHIOPRINE Drug BNF content published by NICE
The use of azathioprine during pregnancy needs to be supervised in specialist units. Manufacturer advises caution impaired metabolism —monitor liver function and complete blood count more frequently in those with severe impairment.
They are mainly used to maintain remission.
Provide GP with clear written advice on required dosage and frequency of azathioprine, written monitoring guidelines and drug information. Check for.
Video: Azathioprine monitoring guidelines Azathioprine(anticancer)-animated quick review
Rheumatology Department DMARD Monitoring Guidelines for Azathioprine. Indications. Licenced for RA, Dermatomyositis and Polymyositis, Autoimmune and.
Blood tests and monitoring for signs of myelosuppression are essential in long-term treatment.
Side-effects, further information Side-effects may require drug withdrawal. Monitor full blood count weekly more frequently with higher doses or if severe renal impairment for first 4 weeks manufacturer advises weekly monitoring for 8 weeks but evidence of practical value unsatisfactorythereafter reduce frequency of monitoring to at least every 3 months.
Transplant patients immunosuppressed with azathioprine should not discontinue it on becoming pregnant. Initially up to 2.